73 PREVALENCE OF SECONDARY HYPERPARATHYROIDISM BY VITAMIN D STATUS IN OLDER IRISH ADULTS
نویسندگان
چکیده
Abstract Background Secondary hyperparathyroidism commonly results from vitamin D deficiency and can lead to accelerated bone turnover loss, especially at cortical sites like the hip. It also attenuate response antiresorptive treatments used for osteoporosis. However, several factors may influence PTH response. We aimed identify prevalence of secondary by categories status in older Irish adults attending a health clinic. Methods The study population consisted (aged over 60 years) clinic large hospital. Participants with serum calcium >2.5 mmol/l eGFR <30 ml/min were excluded avoid cases primary or elevated due advanced renal disease. Hyperparathyroidism was defined as > 65 pg/ml. 25 hydroxyvitamin (25(OH)D) measured liquid chromatography mass spectroscopy. Results There 800 identified, mean age 72.9 +/- 7.9 years, 85.3% female. 25(OH)D 28.1% (<30nmol/l), 17.4% (30-49.9 nmol/l) 8.0% (50-74 nmol/l). Older (P < 0.03) lower = 0.01) associated independent status. Conclusion Nearly one-third patients who deficient (<30 nmol/L) one-sixth insufficient had hyperparathyroidism, similar other studies. observed 8% those levels between 50 -74 nmol/l, suggesting that higher i.e. ≥ 75 nmol/l be preferable adults. Lower independently PTH, consistent previous research. Higher dietary supplemental intake is known suppress response, though we not able account this our study.
منابع مشابه
Vitamin D deficiency and secondary hyperparathyroidism in pediatrics obesity
Obesity is one of the health problems in the developing and developed countries. Obesity subjects the individuals with metabolic and endocrine disorders. It is obvious that vitamin D deficiency or insufficiency may lead to secondary hyperparathyroidism. Thus, obesity increases the risk of vitamin D deficiency. Considering the high prevalence of vitamin D deficiency in children and adolescents w...
متن کاملVitamin D analogues for secondary hyperparathyroidism.
Secondary hyperparathyroidism (2HPT), a common disorder in patients with chronic renal failure, develops in response to phosphate retention and low serum 1,25-dihydroxyvitamin D(3) (1,25(OH)(2)D(3), calcitriol). Replacement therapy with calcitriol or its precursor 1alpha-hydroxyvitamin D(3) (1alphaOHD(3), alfacalcidol) often produces hypercalcaemia, especially when combined with calcium-based p...
متن کاملSecondary hyperparathyroidism due to vitamin D deficiency
Introduction: Vitamin D is increasingly recognized as playing a significant role in combatting many diseases. One is the development of secondary hyperthyroidism due vitamin D deficiency. To date, laboratory quantification methods of serum vitamin D were not well standardized. It could not be established with certainty from which levels of vitamin D certains abnormalities take place, like an el...
متن کاملprevalence of vitamin d deficiency and secondary hyperparathyroidism in non:union: of traumatic fractures.
non:union: is common complication of fracture management. various factors are involved in its occurring. metabolic and endocrine factors are often overlooked. so that aim of study was to evaluate the level of vitamin d and pth in patients with unexplained non:union: and fractures due to low energy trauma. in the case control study, 30 patients with tibial non:union: compared with 32 patients wi...
متن کاملPrevalence of vitamin D deficiency and secondary hyperparathyroidism in nonunion of traumatic fractures.
Nonunion is common complication of fracture management. Various factors are involved in its occurring. Metabolic and endocrine factors are often overlooked. So that aim of study was to evaluate the level of vitamin D and PTH in patients with unexplained nonunion and fractures due to low energy trauma. In the case control study, 30 patients with tibial nonunion compared with 32 patients with nor...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Age and Ageing
سال: 2022
ISSN: ['1468-2834', '0002-0729']
DOI: https://doi.org/10.1093/ageing/afac218.059